Evidence map›Paper›PMID 41353286›Full record

ArticleNPJ digital medicine2025

Uncertainty-aware and causal test-time adaptive foundation model for robust colorectal cancer pathology diagnosis.

Shenghan Lou, Genshen Mo, Xiao Zhang, Hao Wang, Hao Li, Keru Ma, Huiying Li, Xinyue Zhang, Meihong Yan, Haonan Xie and 6 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shenghan Lou *Department of Oncology Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Genshen Mo *Department of Oncology Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Xiao Zhang *Department of Anesthesiology, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Hao Wang *Department of Breast Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Hao LiDepartment of Oncology Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Keru MaDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Huiying LiDepartment of Pathology, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Xinyue ZhangDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Meihong YanDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Haonan XieDepartment of Oncology Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Yuze HuangDepartment of Oncology Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China.
Chuangqi LiTechnology Development Department, QichuangEra Technology Co., Ltd., Beijing, 102699, Beijing, China.
Siyuan MaSchool of Electrical and Electronic Engineering, Nanyang Technological University, Singapore, 639798, Singapore, Singapore.
Hongxue MengDepartment of Pathology, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China. menghongxue@hrbmu.edu.cn.
Lei CaoDepartment of Biostatistics, School of Public Health, Harbin Medical University, No.157 Baojian Road, Harbin, 150081, Heilongjiang, China. Jian_Cheung@hrbmu.edu.cn.
Peng HanDepartment of Oncology Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, 150081, Heilongjiang, China. leospiv@hrbmu.edu.cn.

Funding

Harbin Medical University Cancer Hospital Ascend Leading Disciplines Plan PDYS-2024-14Heilongjiang Provincial Higher Education Institutions Collaborative Innovation Cultivation Project LJGXCG2023-087Heilongjiang Provincial Natural Science Foundation of China LH2023H096the China Postdoctoral Science Foundation 2023MD744213the Postdoctoral research project in Heilongjiang Province LBHZ22210the Scientific research project of Heilongjiang Provincial Health Commission 20230404080339
6 · The paper itself

Abstract

Colorectal cancer (CRC) is a leading malignancy worldwide, where histopathological assessment of hematoxylin and eosin (H&E) stained whole-slide images remains the diagnostic gold standard. However, current computational pathology models suffer from domain shifts, unreliable uncertainty estimation, and spurious correlations, limiting clinical reliability. We present UAD-FM, an Uncertainty-Aware and Causally Adaptive Foundation Model that integrates epistemic-aleatoric uncertainty decomposition, causal test-time adaptation using do-interventions, and post-hoc calibration for trustworthy inference. Across five public CRC datasets (TCGA-COAD/READ, CRAG, DigestPath 2019, NCT-CRC-HE-100K, and LC25000), UAD-FM achieves superior accuracy, calibration, and domain robustness compared with existing foundation models and adaptation baselines. The model also produces interpretable uncertainty maps to support human-AI collaboration. UAD-FM provides a unified, transparent framework for reliable and generalizable CRC pathology diagnosis across heterogeneous clinical settings.

Identifiers

PMID41353286
PMCPMC12738727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.